-
Mashup Score: 1Dr. Soon-Shiong discusses the FDA approval of N-803 in NMIBC - 11 hour(s) ago
“All this is very detailed immunology, I get that, but it sets the stage for what I consider the next evolution of immunotherapy,” says Patrick Soon-Shiong, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 1
“Our research shows that the identification of these genetic factors, even in geriatric patients, is important for determining targeted treatment and overall patient survival,” says Mahdi Taha, DO, FACOI, FACP.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 5
“There’s definitely more work to do to confirm these results on a multi-institutional aspect,” says Ryan L. Steinberg, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 1
“This data emphasizes the importance of utilizing the EPI test for risk assessment of high-risk prostate cancer in [African American] men,” concluded the authors.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 4Urologic surgeons share thoughts on age and performance - 18 hour(s) ago
Results of an exclusive Urology Times survey reveal that more than 70% of respondents said they consider age a relevant factor in the performance of the specialist surgeon.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 10Experts share their key takeaways from AUA 2024 - 1 day(s) ago
In this video, 4 experts discuss the highlights and take-home messages from the 2024 American Urological Association Annual Meeting.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 2
There was a statistically significant reduction in average daily micturition episodes and average daily urgency episodes with vibegron vs placebo.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 10Dr. Braun and Dr. Kenney on unmet needs in kidney cancer - 2 day(s) ago
“What we need is continued work on integrating surgery and systemic therapy,” says Patrick Kenney, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 1FDA accepts BLA for subcutaneous nivolumab in solid tumors - 2 day(s) ago
The FDA is set to have a decision regarding the subcutaneous nivolumab formulation on or by February 28, 2025.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 1
Real-world data showed routine use of darolutamide regimens in community urology practice for patients with metastatic hormone-sensitive prostate cancer.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
Dr. Patrick Soon-Shiong discusses the recent FDA approval of N-803 for BCG-unresponsive NMIBC. @DrPatSoonShiong #blcsm #urology https://t.co/yH9nUQOzUn